Scynexis Inc
SCYX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001178253
No open-market purchases or sales by Scynexis Inc insiders were filed in the last 90 days; 40 institutions reported holding it in 13F filings for Q2 2026, worth $21.0M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Scynexis Inc changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 54 | 53 | −1 |
| Shares | 14.8M | 13.9M | −898.0K (−6.1%) |
| Value | $21.7M | $27.8M | +$6.05M (+27.8%) |
New holders (8)
Institutions that held Scynexis Inc at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Nierenberg Investment Management Company, Inc. | 75,555 | $151.1K | 0.09% |
| LPL Financial LLC | 72,480 | $145.0K | 0.00% |
| Citadel Advisors LLC | 33,037 | $66.1K | 0.00% |
| Two Sigma Securities, LLC | 19,358 | $38.7K | 0.00% |
| Atria Wealth Solutions, Inc. | 11,400 | $22.8K | 0.00% |
| Ritholtz Wealth Management | 11,070 | $22.1K | 0.00% |
| National Bank of Canada | 10,000 | $19.4K | 0.00% |
| Geneos Wealth Management Inc. | 1,800 | $3.60K | 0.00% |
Sold out (9)
Institutions that held Scynexis Inc at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Stonepine Capital Management, LLC | 95,637 | $140.6K |
| Corsair Capital Management, L.P. | 47,396 | $69.7K |
| Millennium Management LLC | 41,726 | $61.3K |
| HRT Financial LP | 16,924 | $24.0K |
| Dimensional Fund Advisors LP | 14,997 | $22.0K |
| Susquehanna International Group, LLP | 14,858 | $21.8K |
| Virtu Financial LLC | 13,633 | $20.0K |
| Simplex Trading, LLC | 10,086 | $14.0K |
| SageView Advisory Group, LLC | 9,070 | – |